109 results found.
          
3Q14 Revenue: DePuy Synthes/Johnson & Johnson
$2,344MM, +2.9% (U.S. $1,272MM, +3.2%, ex-U.S. $1,072MM, +2.4%) Hips +4% (U.S. +4%, ex-U.S. +4%) Knees +5% (U.S. +5%, ex-U.S. +6%) Trauma +3%   Nine months through 3Q14: $7,234MM, +3.0% (U.S. $3,858MM, ...
2Q14 Revenue: Bacterin
$8.9MM, +8% Estimates 2014 U.S. knee and ankle microfracture procedures of ~410,000; shows promise for distribution channel Claims 6.5% U.S. market share in DBM behind Medtronic, DePuy and Integra ~2/3 of revenue arises from spinal fusion ...
2Q14 Revenue: Symmetry Medical
$101.3MM, +2.3% Instruments $29.8MM, +6% Implants $29.4MM, +5% Cases $17.3MM, +1% Other $4.4MM, +29% Surgical $20.4MM, -9%   Announced proposed sale of OEM Solutions business...
BARE BONES® - July 15, 2014
DePuy Synthes/Johnson & Johnson reported 2Q14 orthopaedic sales of US $2,469MM, +3.3% vs. 2Q13. (U.S. $1,294MM, +1.6%, ex-U.S. $1,175MM, +5.3%) (Growth operational, excludes effect of currency) (
2Q14 Revenue: DePuy Synthes/Johnson & Johnson
US $2,469MM, +3% (U.S. $1,294MM, +2%, ex-U.S. $1,175MM, +5%) Hips +5% Knees +1% (U.S. flat, ex-U.S. +4%) Trauma +7% (ex-U.S. +11%) Spine +1% (U.S. -2%, ex-U.S. +4%)   Growth drivers: Succes...
BARE BONES® - April 15, 2014
DePuy Synthes/Johnson & Johnson posted 1Q14 orthopaedic sales of US $2,421MM, +2.7% vs. 1Q13. (U.S. $1,292MM, +2.5%; ex-U.S. $1,129MM, +2.9%; Hips +2%, Knees +3%, Trauma +7%, Spine flat) (Growth operational, r...
1Q14 Revenue: DePuy Synthes/Johnson & Johnson
$2,421MM, +3% (U.S. $1,292MM, +3%; ex-U.S. $1,129MM, +3%) Hips +2% (U.S. +4%) Knees +3% (U.S. +2%, ex-U.S. +6%) Trauma +7% (U.S. +10%, ex-U.S. +4%)) Spine flat (U.S. -3%, ex-U.S. +4%)   Pri...
Arthroscopy/Soft Tissue Repair Market Exceeds $4.5 Billion
The arthroscopy and soft tissue repair market topped an estimated $4.5 billion in 2013, an increase of seven percent from 2012. The market is expected to experience high single-digit growth in each of the next five years, remaining among the healthier segments in the orthopaedic industry.
4Q13/2013 Revenue: Bacterin
4Q13 tissue revenue: $8.3MM, +2% 2013 tissue revenue: $33.1MM, flat Business model going forward: direct sales to orthopaedics and neurosurgery via hybrid model; exploring private label relationships Increased productivity: 25 sal...
BARE BONES® - January 21, 2014
DePuy Synthes/Johnson & Johnson posted 4Q13 orthopaedic sales of US $2,456MM, +4.2% from 4Q12, and 2013 orthopaedic sales of $9,509MM, +23.4% from 2012. (2013 U.S. $5,074MM, +22.4%; ex-U.S.
4Q13/2013 Revenue: DePuy Synthes/Johnson & Johnson
4Q13 orthopaedic revenue: $2,456MM, +4% (U.S. +5%, ex-U.S. +4%) Hips +5% (U.S. +8%, ex-U.S. +2%) Knees +8% (U.S. +9%, ex-U.S. +6%) Trauma +7% (U.S. +10%, ex-U.S. +4%) Total Spine -2% (U.S. -5%, ex-U.S. +2%) ...
BARE BONES® - October 15, 2013
DePuy Synthes/Johnson & Johnson posted 3Q13 orthopaedic sales of US $2,283MM, +1.1% from 3Q12. (U.S. $1,232MM, -0.8%, ex-U.S. $1,051MM, +3.4%; Hips +6%; Knees +3%; Trauma
3Q13 Revenue: DePuy Synthes/Johnson & Johnson
$2,283MM, +1% (U.S. $1,232MM, -1%, ex-U.S. $1,051MM, +3%) Hips +6% (U.S. +7%, ex-U.S. +4%) Knees +3% (U.S. +3%, ex-U.S. +3%) Trauma +1% (U.S. flat, ex-U.S. +2%) Spine -2% (U.S. -10%, ex-U.S. +9%)   ...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - July 16, 2013
DePuy Synthes/Johnson & Johnson reported 2Q13 orthopaedic sales of US $2,385MM, +48.9% vs. 2Q12. (U.S. $1,274MM, +45.9%, ex-U.S. $1,111MM, +52.4%; HIps +4%, Knees +2%, Trauma ...
1Q13 Revenue: Anika Therapeutics
$11.2MM, +12% (U.S. +12%, ex-U.S. +9%) Growth reflects marketing and sales investments from partner, DePuy Mitek, to support awareness of ORTHOVISC Ex-U.S. viscosupplementation sales soft primarily due to reimbursement, country-specific issues ...
1Q13 Revenue: DePuy Synthes/Johnson & Johnson
$2,385MM, +61% (U.S. $1,261MM, +61%, ex-U.S. $1,124MM, +61%) Hips +2% (U.S. +5%, ex-U.S. -0.2%) Knees -0.5% (U.S. +0.5%, ex-U.S. -2%) Trauma +2% (U.S. +2%, ex-U.S. +2%) Spine -7% (U.S. -10%, ex-U.S. -3%) (Including Synthes, -5%)
BARE BONES® - April 16, 2013
DePuy Synthes/Johnson & Johnson reported 1Q13 orthopaedic sales of US $2,385MM, +60.7% vs. 1Q12. (U.S. $1,261MM, +61.0%, ex-U.S. $1,124MM, +60.5%; Synthes ~14% of worldwide sa...
4Q12 and 2012 Revenue: Anika Therapeutics
$49.9MM, +28% (U.S. ORTHOVISC +42%; ex-U.S. ORTHOVISC -17%) 4Q12 revenue: $19.6MM, +69% Extended DePuy agreement for U.S. distribution of ORTHOVISC through 2018 Negotiated distribution and clinical trial reimbursement agreement for ORTHOVI...
4Q12 and 2012 Revenue: DePuy Synthes/Johnson & Johnson
$7,799MM, +36% (U.S. $4,144MM, +34%; ex-U.S. $3,655MM, +39%) Hips +3% (U.S. +4%, ex-U.S. +2%) Knees +3% (U.S. +4%, ex-U.S. +1%) Extremities +4% Spine -3% (U.S. -7%, ex-U.S. +3%)* Trauma +3% (U.S. -1%, ex-U.S. +6%)*...
BARE BONES® - January 22, 2013
DePuy Synthes/Johnson & Johnson posted 2012 orthopaedic sales of US $7,799MM, +36% from 2011. (U.S. $4,144MM, +34%; ex-U.S. $3,655MM, +39%; Hips +3%; Knees +3%; Extremities
3Q12 Earnings: DePuy Synthes/Johnson & Johnson
$2,290MM, +69% (U.S. $1,242MM, +68.5%, ex-U.S. $1,048MM, +68.7%)* Hips +3% (U.S. +6%, ex-U.S. flat) Knees +3% (U.S. +6%, ex-U.S. flat) Trauma +4% (U.S. +1%, ...
BARE BONES® - October 16, 2012
DePuy Synthes/Johnson & Johnson posted 3Q12 orthopaedic sales of US $2,290MM, +68.6% from 3Q11. (U.S. $1,242MM, +68.5%, ex-U.S. $1,048MM, +68.7%) Growth is operational and reflects constant currency, acquisiti...
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - July 17, 2012
DePuy Synthes/Johnson & Johnson reported 2Q12 orthopaedic sales of US $1,628MM, +14% vs. 1Q11. (U.S. $873MM, +13%, ex-U.S. $755MM, +15%) (Excluding Synthes, g...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group